The convergence of deep learning and nanomedicine, known as nano-intelligence, is redefining the landscape of medical imaging for precision diagnosis. Advances in nanotechnology have enabled the evolution of greatly sensitive and specific imaging agents like quantum dots, magnetic nanoparticles, and gold nanostructures, which substantially enhance contrast and target specificity across modalities such as positron emission tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI). These innovations generate extremely high-dimensional and heterogeneous datasets that pose analytical challenges beyond the capacity of conventional techniques. Deep learning models, specifically transformer-based architectures and convolutional neural networks (CNNs), offer powerful solutions through automated feature extraction, nuanced biomarker discovery, and multi-modal data integration. When combined with nanoparticle-mediated imaging, such approaches enable early disease detection, refined tumor characterization, and real-time monitoring of therapeutic responses. Case studies further demonstrate that nano-intelligent diagnostics enhance patient stratification, support adaptive therapy planning, and deliver significant improvements in diagnostic accuracy. This review examines recent advances at the interface of deep learning and nanomedicine, with particular attention to persistent challenges in data annotation, model interpretability, and clinical translation. The incorporation of nano-intelligence into medical imaging holds significant potential to deliver safer, more adaptive, and patient-centered diagnostic strategies, thereby contributing to the foundation of next-generation precision medicine.
No takes yet. Share an insight, caveat, or question.
Rahdar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: